US FDA approves Novartis’ gene therapy for rare muscle disorder
The U.S. Food and Drug Administration has approved Novartis’ gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday. The therapy, branded as Itvisma, was approved…
Lupin receives US FDA approval for its generic cancer drug
Indian pharma major Lupin announced that the US Food and Drug Administration has approved its abbreviated new drug application for Lenalidomide capsules in strengths of 2.5 mg to 25 mg…
